Zacks Company Profile for Precipio, Inc. (PRPO : NSDQ) |
|
|
|
Company Description |
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
Number of Employees: 60 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $12.05 |
Daily Weekly Monthly
 |
20 Day Moving Average: 8,833 shares |
Shares Outstanding: 1.51 (millions) |
Market Capitalization: $18.22 (millions) |
Beta: 1.28 |
52 Week High: $12.45 |
52 Week Low: $3.90 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
7.59% |
2.81% |
12 Week |
112.90% |
81.84% |
Year To Date |
117.52% |
103.74% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Ilan Danieli - Chief Executive Officer
Richard Sandberg - Chairman
Matthew Gage - Chief Financial Officer
Kathleen LaPorte - Director
Ronald Andrews - Director
|
|
Peer Information
Precipio, Inc. (HLIS)
Precipio, Inc. (AZTA)
Precipio, Inc. (APYI)
Precipio, Inc. (RNVA)
Precipio, Inc. (HMSY)
Precipio, Inc. (LRSI)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 74019L602
SIC: 3826
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/12/25
|
|
Share - Related Items
Shares Outstanding: 1.51
Most Recent Split Date: 9.00 (0.05:1)
Beta: 1.28
Market Capitalization: $18.22 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/12/25 |
|
|
|
|